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Critical Evaluation of DichlorvosÕ Breast Cancer Risk
AuthorÕs Note: The reader is encouraged to read the attached document, Appendix B, which includes an explanation of the BCERF
Breast Cancer Risk Classification System, before reading this Critical Evaluation.
I.  Chemical Information
A. Common Names: dichlorvos, DDVP, dichlorfos, DDVF
(Worthing, 1991).
B. Chemical Name: 2,2-dichloroethenyl dimethylphosphate,
2,2-dichlorovinyl dimethylphosphate (Worthing, 1991; WHO,
1989).
C. Chemical Formula: C
4
H
7
Cl
2
O
4
P (WHO, 1989).
D. FormulatorÕ Trade Names: Acivap (Agro Biochemicals
Industries Ltd.); Agro-DDVP (AGRO-SAN Kimya Sanayi ve
Ticaret A.S.); ANAPAV, ANOPOVDDVP; Fly Fighter
(AMVAC); Dedevap, Mafu, Oku (Bayer); Cekusan (Cequisa);
Chimac DVP (Chimac-Agriphar S.A.); Devikol (Devidayal Pvt.
Ltd.); Didivane (Diachem S.p. A.) Herkol, Marvex Super, No-
Pest Strips, Prentox DDVP, Vapona, Verdican, Verdipor,
Verdisol, Elastrel (Fermenta Animal Health); Luvon (Lupin
Agrochemicals Ltd.) Vapona (Micro flo Co.); Midiltipi DDVP
(Midiltipi Agro-Chemicals, Inc); Dadasul (Sulphur Mills Ltd.);
De De Vap (Vapco) (Meister, 1998).
E. Trade Mixes: Fly-Die (+ piperonyl butoxide + pyrethrins)
(HACO, Inc.); Ransbeck (+ phosalone) (Rhone-Poulenc);
Safrotin Aerosol (+ propetamphos) (Sandoz Agro, Inc); Piran
(+ dibromochloropropane) (Tamogan Chemicals Ltd.) (Meister,
1998).
F. CAS Registry Number: 62-73-7 (WHO, 1989).
G. Chemical Structure:
H. Major Metabolites: dimethyl phosphoric acid and
dichloroacetic acid (WHO, 1989).
II.  History of Use and Usage:
A. History of Use and Nomenclature:
Dichlorvos is a synthetic insecticide and belongs to the family of
chemically related organophosphate pesticides (OP). Although first
synthesized in the late 1940s (IARC, 1991), its commercial
manufacture started much later, in 1961. The annual production
of dichlorvos was as high as 4.2 million pounds (lbs) in the late
1970s, and fell to 992,000 lbs by 1989. More recent estimates are
not available, but are likely to be lower due to the many recent
cancellations of its use (ATSDR, 1997). Dichlorvos can be released
into the environment as a major degradation product of other OP
insecticides, such as trichlorfon, naled, and metrifonate (Hofer,
1981; Murphy et al., 1996; ATSDR, 1997; Pettigrew et al., 1998).
Dichlorvos can kill insects when ingested, or absorbed through
the integument or via spiracles (Worthing, 1991). It is effective
against a wide range of pests such as mushroom flies, aphids, spider
mites, caterpillars, thrips, whiteflies, gypsy moth, spruce budworm,
forest tent caterpillars, fruit flies, codling moth, corn borer and
boll weevil (Meister, 1998).
B. Usage:
In agriculture, dichlorvos was used to protect stored crops from
insect damage. It was used in livestock industry to control external
parasites on animals such as fleas and ticks. Dichlorvos was also
added in animal feed as an anthelmintic (worming agent) for swine,
horses and dogs (ATSDR, 1997). It was used in mushroom houses
to control flies and insects (IARC, 1979), and was added directly
to the water in fish farms, to control fish parasites (WHO, 1989).
Dichlorvos was used in food processing and packaging rooms,
and in food service establishments to control insect pests (USEPA,
1995). In 1974, dichlorvos ranked among the three pesticides that
were most frequently applied by pest control operators (ATSDR,
1997). Besides agricultural use, dichlorvos was applied as a
fumigant in outdoor and public use areas to control Diptera and
mosquitoes, and thus prevent the spread of malaria (ATSDR, 1997).
It was used to control flies, mosquitoes, caterpillars, cockroaches
and other pests in buildings, aircraft, public transportation vehicles
and outdoor areas (ATSDR, 1997; WHO, 1989). Dichlorvos was
a popular household insecticide that was applied as an aerosol or
liquid spray, or incorporated into resin strips and flea collars for
pets. The National Household Pesticide Usage study reported that
dichlorvos was the most frequently detected pesticide in 8,254
households surveyed in the U.S. during the mid-1970s (ATSDR,
1997).
The annual agricultural use of dichlorvos was estimated as
248,000 lbs during 1982 (ATSDR, 1997). Estimates done in late
1980s indicate that 60% of dichlorvos used worldwide was for
plant protection, 30% was for public hygiene and vector control,
and 10% to protect stored crops (WHO, 1989). In the U.S., use in
         O
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livestock (beef, dairy, swine sheep, poultry, other animals)
industries, tobacco warehouses and greenhouses accounted for
approximately 60% of all the dichlorvos used in 1988. In the same
year, food processing, sanitation and public health used 25%, and
the rest (15%) was used for domestic purposes (against household
pests and in pet collars and No-Pest Strips) (Mueller, 1988).
Dichlorvos was among the several organophosphate pesticides
(OP) shipped by the Department of Defense for use during the
Gulf War (GWVI, 1996).
III.  Current Regulatory Status:
A. Regulatory Status:
Based on evidence from animal studies in the late 1980s, the
Environmental Protection Agency (EPA) classified dichlorvos as
a Òprobable human carcinogen.Ó On February 24, 1988, EPA
initiated a Special Review for pesticide products containing
dichlorvos in response to concerns about its carcinogenicity and
neurotoxic potential. The Special Review is EPAÕs formal process
to determine if the use of a pesticide poses unreasonable risks to
people or the environment. All labels of dichlorvos products were
revised to include the signal words ÒDanger-PoisonÓ and directions
for appropriate use. There were concerns about exposure to
dichlorvos through food residues, during application, or reentry
after application, and through treatment of pets (USEPA, 1995).
In 1995, EPA proposed cancellation of many domestic uses such
as hanging pest strips, room foggers and pet flea collars. It proposed
cancellation of use of dichlorvos on: stored non-perishable raw
and processed foods, in warehouses, commercial institutions,
industrial areas, food manufacturing and processing facilities, on
ornamentals, on turfgrass and in airplanes (ATSDR, 1997). The
uses that were proposed to remain were: for insect control in
mushroom houses, greenhouses, kennels, garbage dumps, manure
piles and animal premises; for automated application to livestock;
fumigation of passenger buses; and in insect traps. Treated areas
were required to have warning signs posted to restrict re-entry
(ATSDR, 1997).
In response to EPAÕs proposed cancellations, Amvac Chemical
Corp., the sole registrant of technical dichlorvos (99.9% active
ingredient), voluntarily agreed to delete certain household, food
crop, aerial and aircraft applications of dichlorvos (USEPA, 1995).
Amvac was allowed to sell its existing stocks with old labels for a
one-year period, ending in 1996. Household use of dichlorvos has
since been restricted to dog and cat flea collars, impregnated resin
strips and total release foggers. Non-total release foggers and
aerosols were restricted to be applied by licensed pest control
operators only (USEPA, 1995). A new fact sheet has been prepared
by the EPA for Òbug bombsÓ or total release foggers to explain
and emphasize the label requirements on such devices (USEPA,
1998a). The Food and Drug Administration (FDA) has required
that labels of pest-strips carry warnings to discourage their use in
restaurants and kitchens (ATSDR, 1997).
B. Clean Water Act Requirements:
Dichlorvos has been designated as a hazardous substance under
the Federal Water Pollution Control Act and is regulated by the
Clean Water Act Amendment. Discharges of 10 lbs or more of
dichlorvos need to be reported to the National Response Center
(HSDB, 1997). However, Maximum Contaminant Levels (MCL)
or Health Advisories (HA) have not been established (USEPA,
1996). Dichlorvos has not been detected in drinking water in the
U.S. (ATSDR, 1997). It is rapidly hydrolyzed in water to dimethyl
phosphoric acid and dichloroacetic acid (WHO, 1989).
C. Workplace Regulations:
The Occupational Safety and Health Administration (OSHA) has
set the maximum allowable level in workplace air at 1 mg/m3,
based on average exposure of 8 hours / day, 40 hours / week
(ATSDR, 1997).
D. Food Tolerances:
The maximum amount of each pesticide that is permitted to occur
on the edible portion of raw agricultural commodities and in
processed foods, called ÒtoleranceÓ, is set by the EPA. For some
pesticides such as dichlorvos, the residues may decline rapidly,
and the limits are set for the levels detectable at harvest (IARC,
1991). The tolerances for dichlorvos are: 0.05 parts per million
(ppm) in tomatoes; 0.5 ppm in cucumbers; 1 ppm in lettuce;
0.02 ppm in milk; 0.05 ppm in eggs and poultry meat; and
0.02 ppm in goat, sheep and cattle meat (USEPA, 1998b).
A strict interpretation of the Delaney Clause would mandate a zero
tolerance of any chemical shown to cause cancer in man or animal,
in ready-to-eat or processed food. Dichlorvos was reported to cause
cancer in experimental animals in the late 1980s (Chan et al., 1988;
Chan et al., 1991). Dichlorvos food tolerances were thus potentially
violating the Delaney Clause. In 1991, the Federal Food, Drug
and Cosmetic Act (FFDCA) proposed to revoke the food additive
regulation that permitted dichlorvos use on packaged or bagged
non-perishable food. This revocation was stayed indefinitely after
a petition from Amvac, but the use of dichlorvos on packaged
foods has been proposed for cancellation (USEPA, 1995).
IV. Summary of Evidence of Overall Carcinogenicity
(non-breast sites)
A.  Human Studies:
There are many reports on the clinical and non-cancer effects of
dichlorvos. These effects are mainly mediated through its inhibition
of acetyl cholinesterase enzymes. Dichlorvos has also been
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implicated as a causative agent of contact dermatitis in case-control
studies (Matsushita et al., 1985). Toxic effects of dichlorvos have
been extensively reviewed (IARC, 1991; ATSDR, 1997; Gillett et
al., 1972; Tinker, 1972; WHO, 1989) and are not included here to
restrict the discussion to carcinogenic effects.
1. Case Reports:
Case-reports of exposure and subsequent diagnosis of cancer are
not sufficient evidence to establish a cause and effect relationship.
Cancer has a long and variable latency period during which time a
person is typically exposed to many potential carcinogens.
However, case-reports can serve as useful indicators for an
association that needs to be followed in large epidemiological
studies.
One report documents that parents of two cases of childhood
leukemia recalled using dichlorvos and propoxur (Reeves et al.,
1981). This case-report is not adequate evidence in itself for a
cancer causing potential of dichlorvos.  However, it adds weight
to the evidence from case-control studies of leukemia discussed
below.
2. Population-Based Case-Control Studies
A few case-control studies have evaluated the risk for cancer in
association with exposure to dichlorvos and other pesticides.
However, all the studies were based on small numbers of cases,
making them inadequate as evidence for a carcinogenic effect of
dichlorvos in humans. They do raise some concerns that need to
be addressed in future studies.
In one case-control study, 578 leukemia cases among white male
farmers in Iowa and Minnesota and 1245 population-based controls
were evaluated for exposure to pesticides (Brown et al., 1990).
The odds ratio (OR) for leukemia was significantly increased
among the 26 farmers who had ever mixed, handled or applied
dichlorvos (OR = 2.0; 95% confidence interval (CI) 1.2-3.5). The
risk was higher among the 12 farmers who had used dichlorvos at
least 20 years before the time of interview (OR = 2.4; 95% CI
1.1-5.4). The risk was elevated among farmers who used dichlorvos
on animals frequently (> 10 days per year), based on a small sample
of five cases and four controls. This study adjusted ORs for vital
status, age, state of residence, tobacco use, family history of
lymphopoietic cancer, high-risk occupations and high-risk
exposures in a logistic analysis. However, the number of farmers
exposed to dichlorvos was small. Since questionnaires were used
to assess exposure to dichlorvos, recall bias could not be ruled
out. Increased risk for leukemia in this study was also observed in
association with other pesticides, and the role of dichlorvos, by
itself, could not be evaluated due to the small number of cases
diagnosed.
The above population of white male farmers was also evaluated
for risk of developing non-HodgkinÕs lymphoma (NHL) (Cantor
et al., 1992). The risk for NHL was slightly, but not significantly
increased in farmers who had ever handled dichlorvos (OR = 1.2;
95% CI 0.7-2.2, based on 20 cases and 38 controls), or among
those who had handled it prior to 1965 (OR = 1.8; 95% CI 0.8-3.9,
based on 12 cases and 17 controls). The ORs were adjusted for
vital status, age, state, cigarette smoking status, family history of
lymphopoietic cancer, high-risk occupation and high-risk
exposures.
A different population-based case-control study from eastern
Nebraska evaluated the risk for NHL among white women
agricultural pesticide users. This study included 184 NHL cases
and 707 controls matched for race, sex, vital status and age. Among
the six cases and five controls who had personally handled OPs,
the OR for NHL was significantly increased (OR = 4.5, 95% CI
1.1-17.9) (Zahm and Babbitt, 1993). However, dichlorvos was one
of several OPs that the women could have been exposed to, and
only one of the women interviewed reported having handled
dichlorvos specifically. The very small numbers in both these
studies do not allow an evaluation of the effect of dichlorvos on
the risk for NHL.
A case-control study has evaluated the incidence of multiple
myeloma among 173 white male farmers in Iowa and 650
population-based controls (Brown et al., 1993). The risk for
multiple myeloma was found to be increased, but not significantly,
among farmers who had ever mixed, handled or applied dichlorvos
as an animal insecticide (OR = 2.0; 95% CI 0.8-5.0), based on
seven cases and 21 controls. Failure to use protective equipment
did not increase the risk further. The ORs were adjusted for vital
status and age. Smoking and education were evaluated, but not
found to be confounding factors.
Families of 153 cases of childhood cancer cases identified through
the Missouri Cancer Registry and 85 cancer-free white children
were interviewed for home use of pesticides. Almost 10% of the
participating families acknowledged use of dichlorvos containing
No-Pest StripsÒ (Davis et al., 1992). A comparison of 45 brain
cancer cases and 85 cancer-free controls indicated a significantly
increased risk for childhood brain cancer (OR = 3.7; 95% CI 
1.0-13.7) associated with family use of No-Pest StripsÒ. The
increased risk for brain cancer was not significant if the comparison
was done with a control group of 108 other childhood cancer cases
(OR = 2.0; 95% CI 0.6-6.3) (Davis et al., 1993). This study was of
limited value because of the small number of subjects, potential
for recall bias and the lack of detailed exposure information. It
does indicate the need for larger case-control studies on population
groups who may have been exposed as children to dichlorvos and
subsequent cancer incidences.
3. Cohort Studies:
Mortality rates of a cohort of 2384 manufacturing workers (87%
white men, 10% white women, 3% black men, <1% black women)
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at a plant in Colorado that produced aldrin, azodrin, Vapona
(dichlorvos) and other pesticides were compared to the general
population of Colorado State. The median follow-up period was
29 years for the cohort, with a minimum follow-up of 11 years for
any employee. The vital status of the subjects was determined
through the National Death Index, the Social Security
Administration Death Files, the Colorado Division of Motor
Vehicles, a credit bureau and individual tracing. The standardized
mortality ratio (SMR) was calculated as the ratio of deaths among
cohort members to the expected number of deaths, multiplied by
100. The overall cancer mortality rate of the cohort was similar to
that recorded for the general population of Colorado State. The
SMR for lymphopoietic cancer in the cohort was slightly, but not
significantly increased (SMR = 146; 95% CI 83-237). However,
this increase was significant among black males, based on three
deaths (SMR = 1318; 95% CI 272-3853, p < 0.05). A common
exposure pattern or a single causative exposure was considered
unlikely for these three workers since they had held different job
responsibilities (Amoateng-Adjepong et al., 1995). White women
in this cohort had no overall increase in deaths from all causes,
but a non-significant increase was observed in deaths from lung
cancer (SMR = 256; 95% CI 53-747) (Amoateng-Adjepong et al.,
1995). There was a significant increase in rate of hepatobiliary
cancer in the group of white, male workers who were hired between
1950-1959, based on 5 deaths (SMR = 427; 95% CI 139-997,
p < 0.05). These five cases had been hourly workers with a high
potential for pesticide exposure. However, the period of
employment associated with the increased mortality (1950-1959)
predates the start of commercial manufacture of dichlorvos in 1961,
making dichlorvos exposures unlikely as the cause. The incidence
of hepatobiliary cancers was not significantly increased in the rest
of the cohort (Amoateng-Adjepong et al., 1995).
4. Summary:
Male farmers in the Midwest who handled dichlorvos were found
to have a significantly increased risk for leukemia in one case-
control study (Brown et al., 1990). Risk for NHL or multiple
myeloma was not observed to be significantly increased in male
farmers who had used dichlorvos (Brown et al., 1993; Cantor et
al., 1992). The risk for NHL was significantly increased among a
very small group of female farmers who had used OP, but only
one woman reported using dichlorvos (Zahm and Babbitt, 1993).
Another study reported family use of dichlorvos to be associated
with a significantly increased risk for childhood brain cancer (Davis
et al., 1993). The small numbers and potential for exposure to
other pesticides in the two studies indicating positive associations
(Brown et al., 1990; Davis et al., 1993), do not permit an evaluation
of whether dichlorvos caused the increase in incidence of leukemia
or brain cancer. However, both these studies raise concerns about
possible carcinogenic effects from dichlorvos exposure in humans
that need to be followed in larger populations-based case-control
studies.
B. Animal Experimental Studies:
There have been many studies on the carcinogenic effects of
dichlorvos in experimental animals. Some of the studies described
below provide evidence for a cancer-causing effect of dichlorvos
at contact sites such as the stomach and esophagus. Studies that
reported on mammary neoplasms are discussed in Section VB.1.
1. Mice:
In a study conducted by the National Cancer Institute (NCI), groups
of 50 male B6C3F1 mice were given 0, 10, 20 mg/kg dichlorvos
(99% pure) by gastric intubation, 5 times / week for 103 weeks.
Groups of 50 females were similarly treated, but with 0, 20, or
40 mg/kg of dichlorvos. Average survival rates were 70% for
control males, 50% for control females, 56% for dichlorvos-treated
males and 63% for dichlorvos-treated females. There was a
significant increase (p < 0.01) in squamous cell papillomas in the
forestomach of female mice, but only in the high-dose group (18/
50). The incidence of squamous cell papillomas in the low-dose
group females (6/49) was not significantly different to that in the
controls (5/49). Forestomach carcinomas were found in two
females in the high-dose group, but none in the vehicle-treated
controls. The combined incidence of papillomas or carcinomas in
the stomach of female mice was significantly increased in the high
dose group (p < 0.01). The incidence of squamous cell papillomas
of the forestomach was increased in male mice as well, but not
significantly (Chan et al., 1991). The low survival rates may have
reduced the effective numbers of mice that survived long enough
for tumors to develop. Although the number of surviving animals
was small, the histopathological evidence of tumor progression
and the dose-dependent increase of lesions in treated female mice
suggest a carcinogenic effect of dichlorvos at a primary site of
contact, the forestomach.
An earlier NCI study evaluated B6C3F1 mice (50 per dose of each
sex) that were given TWA (time-weighted average) doses of
0, 318 and 635 ppm dichlorvos in diet for 78 weeks. Surviving
mice were killed 92 to 94 weeks after initiation of treatment.
Survival rates were not dose-related. The overall incidence of
tumors was increased in male mice that were fed the low-dose of
dichlorvos (p = 0.050). There was one esophageal squamous cell
carcinoma per group of male mice fed the low-dose and female
mice fed the high-dose of dichlorvos (NCI, 1977). Three male
mice that were fed the low-dose, and one female fed the high-dose
of dichlorvos, had focal hyperplasia in the esophagus (NCI, 1977).
Although these increases were not statistically significant, their
observation was important since spontaneous esophageal tumors
are rare in this strain of mice.
In one study, C57B1/6 mice (100 of each sex) were treated with
0 or 0.2 mg dichlorvos (97%) by gavage, either two to three times
a week over 50 weeks. Both, dichlorvos-treated males and females
had significantly increased incidence of focal hyperplasia of the
urinary bladder compared to controls. Details on statistical analysis
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and experimental design were not available. The authors reported
no significant increase in treatment-related neoplastic lesions [Horn
et al., 1987, as translated in (FAO/WHO, 1993)]. The study was
inadequate as a cancer bioassay since it used only one treatment
dose and did not allow an evaluation of a dose-response effect.
Horn et al. conducted a follow-up co-carcinogenicity study, in
which similar dichlorvos treatment of mice were accompanied by
a weekly subcutaneous dose of 50 µg N-nitrosodiethylamine over
50 weeks (statistical analysis and details on experimental design
not available). Dichlorvos was not found to act as a co-carcinogen
in this study [Horn et al., 1990, as cited in (FAO/WHO, 1993)].
The short time period (50 weeks) of treatment in both these studies
make them invalid as bioassays for cancer.
An unpublished study by Konishi et al., reviewed by (Bremmer et
al., 1988), on B6C3F1 mice (50 of each sex) treated with 0, 62 or
124 mg/kg dichlorvos in drinking water for 102 weeks, reports a
dose-dependent decrease in all tumors in females. No details on
experimental design were available. Since dichlorvos is rapidly
hydrolyzed in water, the actual dose received by animals treated
using drinking water may have been lower.
2. Rats:
The carcinogenic effect of dichlorvos was evaluated in Fischer
F344/N rats (50 per dose, of each sex) treated by gastric intubations
with 0, 4 or 8 mg/kg dichlorvos (99% pure), five times per week,
over 103 weeks. Survival rates were 62% for controls and 50%
for treated animals. A significant increase in incidence of
hyperplasia and multiple adenomas of the pancreas (p < 0.05) was
observed among male rats. Although pancreatic acinar atrophy
was significantly increased in the high dose-treated female rats (p
< 0.05), there was only a small, non-significant increase in
pancreatic acinar hyperplasia (Chan et al., 1991). There was a
significant and dose-dependent increase in the incidence of
mononuclear cell leukemia in dichlorvos-treated male rats
(p < 0.02). In female rats, the increased incidence of mononuclear
cell leukemia was small and not significant.
The low survival rates of both the controls and treated rats in this
study indicate that the animals may have been dying of other, non-
treatment related causes. Early deaths in animals can lead to an
underestimation of slow developing cancers that would become
detectable with age had the animals lived longer. One reviewer of
the study has pointed out that variable and high rates of spontaneous
mononuclear cell leukemia are common in corn oil-dosed male
F344 rats, with rates ranging between 4% to 46%. The increase in
incidence of mononuclear cell leukemia in treated rats, although
significant, does not exceed the range that has been observed for
this strain of rats in controls of other bioassays (Bremmer et al.,
1988; Mennear, 1994). Details on the incidence of mammary
fibroadenomas observed in this study are discussed in Section
VB.1.
Other studies described below had either strong limitations, or were
invalid as cancer bioassays for the reasons outlined below after
each studyÕs design.
Osborne-Mendel rats (50 of each sex) were fed 0, 150 ppm (male)
or 326 ppm (female) TWA of dichlorvos over 80 weeks. The
surviving animals were killed at 110-111 weeks. Histopathological
analysis of the treated animals revealed no treatment-related effects
(NCI, 1977). This study was of limited value as a cancer bioassay
since it used only one treatment dose.
In a two-year inhalation study, groups of 50 Carworth Farm E rats
(CFE) of each sex, were exposed to 0, 0.05, 0.5 and 5 mg/m3 of
dichlorvos. The survival rates in treated and control groups were
very low, but not treatment-dependent. Only 11/50 controls and
15/50 males treated with 0.5 mg/m3 dichlorvos survived the
experimental period. Survival of female rats was relatively higher,
with 50% of controls and 64% treated rats surviving the
experimental period. The incidence of tumors of the thyroid,
adrenal and anterior pituitary was higher in treated males (statistical
comparison with controls was not available for each organ site).
The group of males that were fed the highest dose however, had a
significant decrease in incidence of tumors of the adrenal medulla
(p < 0.05). Tumors in the anterior pituitary were slightly but not
significantly increased in the treated females (p > 0.05). The poor
survival rates of the control rats in this study made a comparison
of dose-related effects meaningless (Blair et al., 1976).
In an unpublished study that has been reviewed by EPA, CD rats
(40 per dose of each sex) were fed 0, 0.1, 10, 100, and 500 ppm of
the insecticide Vapona¤ for 104 weeks (93% dichlorvos).  No
oncogenic effects for dichlorvos were reported; however, EPA
noted that the maximum tolerated dose (MTD) was not included
in this study. Further, the number of animals that were examined
after the full 24-month period was small, and no histopathological
details were available (Witherup et al., 1967, as cited in USEPA,
1982). Another study conducted by the same authors was also
invalid as a cancer bioassay because of the very small number of
animals used, the very low survival rates and the use of only one
treatment dose (USEPA, 1982; Witherup et al., 1971).
In an unpublished study by Enomoto et al. (as reviewed in WHO,
1989), Fischer rats were treated with 0, 140, or 280 mg/L of
dichlorvos in drinking water for 104 weeks. No treatment related
effect on tumor incidences was reported.  Since dichlorvos breaks
down in water rapidly, the effective dose in this study may have
been much lower.
3. Dogs:
Beagle dogs (three of each sex) were fed 0, 0.09, 0.32, 3.2, 32 and
256 mg/kg dichlorvos in diet for two years [unpublished study by
Jolley et al., 1967, as reviewed by (Bremmer et al., 1988)]. No
6 Cornell University Program on Breast Cancer and Environmental Risk Factors in New York State
increases of any tumors were observed among treated dogs. The
number of animals used were inadequate for a cancer bioassay.
Summary, Animal Studies:
A study that was conducted with appropriate experimental design,
although limited by its poor survival rates, indicated a significant
increase in incidence of stomach tumors in female mice and
pancreatic tumors in male rats that were fed dichlorvos (Chan et
al., 1991). The increase in tumors in the forestomach in female
mice and pancreatic tumors in male rats was dose-dependent,
indicating a treatment-related effect. The incidence of esophageal
cancers in dichlorvos-treated mice in another study deserves
attention since spontaneous cancers at this site are rare. Also, the
esophagus is similar to the forestomach, in being a primary site of
contact for ingested dichlorvos (NCI, 1977). The increase in
incidence of leukemia in male rats (Chan et al., 1991) deserves
further attention in light of the evidence, although limited, from
human case-control studies discussed previously in Section IVA.
Other studies on experimental animals did not indicate dichlorvos
treatment-related effects, but were invalid as cancer bioassays due
to the small number of animals (Witherup et al., 1971), or
inadequate reporting (Blair et al., 1976; Witherup et al., 1971).
C.  Current Classification of Carcinogenicity by Other Agencies
1. IARC Classification:
The IARC has classified dichlorvos in Group 2B, possibly
carcinogenic to humans (IARC, 1991). This classification is based
on inadequate evidence in humans and sufficient evidence in
experimental animals for the carcinogenicity of dichlorvos (IARC,
1991).
2. NPT Classification:
On the basis of studies of experimental animals, the NTP has
concluded that in rats, there is some evidence from males and
equivocal evidence from females, and in mice, there is some
evidence from males and clear evidence from females for the
carcinogenic effect of dichlorvos (ATSDR, 1997).
3. EPA Classification:
The EPA has classified dichlorvos as a Group B2, probable human
carcinogen (ATSDR, 1997). This classification was based on
sufficient evidence for carcinogenicity from studies on
experimental animals on dichlorvos.
V.  Critical Evaluation on Breast Carcinogenicity
A.  Human Studies:
Human Tissue Levels:
Studies of human tissue levels in association with breast cancer
were not available.
B.  Animal Studies:
1. Mice:
Two long-term carcinogenicity studies in mice that were discussed
in Section IVB.1, did not report any increase in the incidence of
mammary gland neoplasms in dichlorvos-treated animals (Chan
et al., 1991; NCI, 1977).
2. Rats:
In one study, groups of 50 female Fischer F344/N rats were treated
with 0, 4 mg/kg and 8 mg/kg dichlorvos (99% pure) by gavage for
103 weeks (Chan et al., 1988; Chan et al., 1991). Survival rates
were 62% for controls and 50% for treated animals. The number
of mammary gland tumors found in each group are presented in
Table 1.
Significant increases in incidence of mammary fibroadenomas
(benign), were observed in both groups of dichlorvos-treated
females (p < 0.05). The incidence of malignant neoplasms was
not increased. When the incidence of all benign and malignant
neoplasms was combined, a significant increase was observed in
the group fed the low dose, but not the group that was fed the high
dose of dichlorvos (p < 0.02), indicating a lack of a dose-dependent
response (Chan et al., 1991). The low survival rates and the use of
only two doses were limiting factors of this study. The strength of
this study was that histopathology was done on all animals,
including those that did not survive the full term of the experiment.
However, it is difficult to predict if the benign mammary gland
tumors observed to be significantly increased in the treated animals
would have progressed to become malignant lesions with
increasing age or longer survival time.
In an inhalation study conducted by Tunstall Laboratories (Shell
Research Ltd.), groups of 50 female CFE rats were exposed to 0,
0.05, 0.5 or 5 mg/m3 atmospheric concentration of dichlorvos for
two years (> 97% purity). No treatment-related increases in
mammary lesions were observed. The controls had very high rates
of spontaneous mammary tumors and very low survival rates (Blair
et al., 1976). In the high dose-treated females, there was a
statistically significant decrease in the incidence of mammary gland
tumors (p < 0.01) (Blair et al., 1976). Details on the numbers of
Type of Mammary
Gland Lesion
Vehicle
Control
4 mg/kg 8 mg/kg
fibroadenoma
multiple fibroadenomas
carcinomas
mammary neoplasms
(total)
9
0
2
11
19*
6*
2
20**
17*
3
0
17
*Significantly different from controls, p < 0.05
**Significantly different from controls, p < 0.02
Table 1. Mammary Gland Lesions Observed in
Dichlorvos - Treated Rats
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dose group and one each, in the pooled controls and the low-dose
group had mammary carcinomas. The use of only five rats as
matched controls was a limiting factor of this study (NCI, 1977).
Reuber re-examined the histological sections from the above NCI
study and reported that the dichlorvos-treated male rats had an
increased incidence of mammary gland neoplasms. Malignant or
benign neoplasms were not significantly increased in either the
low-dose or the high-dose groups of male mice when analyzed
separately. However, the incidence of malignant mammary gland
neoplasms were reported in the review as significantly increased
when the entire group of treated male rats (low-dose and high-
dose) was pooled and compared to the controls (p = 0.002) (Reuber,
1981). A significant increase in carcinomas of endocrine organs
(thyroid, adrenal, pituitary and ovary) was reported for the low-
dose treated females (p = 0.000088). Combining the results of
different treatment groups and different organ neoplasms in the
review makes the significance of the results unclear, especially
since the results of individual endocrine cancers were not
statistically significant. It was also not mentioned in this review if
rats with neoplasms in multiple organs (metastatic tumors) were
counted as one or as multiple tumors.
3. Summary, Critical Evaluation on Breast Carcinogenicity:
No epidemiological studies were available to evaluate the breast
carcinogenicity of dichlorvos in women exposed to this insecticide
in the past.
A study by Chan et al. (1991) has reported increased (significant
in low dose group only) incidence of mammary gland
fibroadenomas/adenomas in Fischer rats. Two other studies have
reported no significant increase in incidence of mammary gland
neoplasms among dichlorvos treated rats (Blair et al., 1976; NCI,
1977), but these studies were limited by either low survival rates,
small numbers or high rates of spontaneous mammary gland
neoplasms. However, one reviewer of the NCI study (Reuber, 1981)
reported that dichlorvos had caused a significant increase in
incidence of mammary gland neoplasms in dichlorvos-treated male
Osborne-Mendel rats. Two studies in mice did not report increased
incidence of mammary gland neoplasms in dichlorvos fed mice
(Chan et al., 1991; NCI, 1977). There is a need for another study
in rats, using more doses of dichlorvos and better survival rates to
verify the results of Chan et al. (1991).
C. Other Relevant Data on Breast Cancer Risk:
1. Evidence of Endocrine Disruption:
a) Effects on Steroidogenesis:
Sprague-Dawley rats (six per group) were treated with 0 or 2 ppm
dichlorvos (99% pure) in drinking water for two weeks and
evaluated for hormonal disruptions. Dichlorvos was not found to
affect the plasma and adrenal corticosterone levels, but did increase
the levels of adrenal cholesterol ester and adrenocorticotrophic
hormone (Civen et al., 1980). The same author had previously
reported a significant inhibition of pregnenolone-stimulated
steroidogenesis using 10 µM dichlorvos in vitro on isolated adrenal
cells (p < 0.001) (Civen et al., 1977). These studies indicate that
dichlorvos may have the potential to disrupt steroidogenesis.
Juvenile male Wistar rats that received either 10 mg/kg of
dichlorvos, from day 4 to 23 of life, or 20 mg/kg dichlorvos on
day 4 and 5 had a small, but not significant reduction in
spermatocytes (Krause et al., 1976). No significant reduction was
observed in serum levels of testosterone, luteinizing hormone, or
follicle stimulating hormone in adult Wistar rats that were fed
10 mg/kg dichlorvos every second day over two weeks, or 5 mg/
kg dichlorvos three times a week for three weeks (Krause, 1977).
b) Delayed Onset of First Estrous Cycle:
Outbred albino rats (n = 29), exposed to 2.4 mg/m3 of dichlorvos
in environmental chambers, were observed to have their first
estrous cycle significantly later (p = 0.005) than unexposed controls
(n = 21). One half of a No-Pest StripÒ was suspended on top of
each cage and the rats were exposed to this environment for 8 to
10 hours daily, from birth until the first estrous (Timmons et al.,
mammary tumors in each group were not reported and the high
rates of spontaneous mammary tumors prevent meaningful
conclusions from this study.
The above study was reviewed by Reuber (1981), who concluded
that Òbenign and malignant neoplasms, as well as neoplasms of
the thyroid, pituitary, adrenal and mammary gland were increased
in dichlorvos-treated male ratsÓ (Reuber, 1981). The basis for the
conclusion of this review is unclear since: 1) the numbers of
mammary tumors were not reported in the original paper (Blair et
al., 1976), and 2) Reuber states in his review that he was denied
permission to examine the slides (Reuber, 1981).
In a study conducted by NCI (1977), Osborne-Mendel rats (50 per
dose, of each sex) were fed a TWA dose of 150 ppm or 256 ppm
dichlorvos in corn oil in diet for 80 weeks. Five untreated rats
served as matched controls for each of the two treatment groups.
Matched control groups from studies of five other chemicals were
combined to form a pooled control group of 60 animals of each
sex. The surviving animals were killed at 110-111 weeks.
Mammary gland neoplasms (benign and malignant) were reported
in 12% of the females in the high-dose group, 27% of the females
in the low-dose, 20% of the matched controls, and 18% of the
pooled controls. The increased incidence of mammary neoplasms
in the low-dose group was not statistically significant and was
mainly of the benign kind (mammary fibromas and
fibroadenomas). Only one mammary carcinoma was detected in
the low-dose group, while two mammary carcinomas were
observed in pooled controls. In male rats, two animals in the high-
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1975). The result of this study indicates a delay in an estrogen-
dependent event. However, this study did not test for other
indicators for estrogenic effects and it is not sufficient to predict
an antiestrogenic action for dichlorvos.
2. Reproductive and Teratogenic Effects:
Reproductive toxicity may be suggestive of either endocrine
disruption or embryo toxicity. We have included below any studies
on reproductive toxicity of dichlorvos that indicate an effect on
estrogen-dependent reproductive events.
One study evaluated the reproductive performance of two different
mammalian species exposed to dichlorvos by either gavage or
inhalation. CF-1 mice (n = 25) were given the MTD of dichlorvos
(60 mg/kg, 96% pure) by gavage from day 6 through 15 of
gestation. New Zealand Rabbits (n = 12) were similarly treated
with a 5 mg/kg dose from day 6 through 18 of gestation. Another
group of mice (n = 15) and rabbits (n = 14) were exposed to
dichlorvos vapor (4 µg/L for 7 hours per day). No effects on litter
sizes or implantation rates were observed in any of the exposed
groups in either species (Schwetz et al., 1979).
Similar results were observed in a different study in which Dutch
rabbits (n = 20/ group) and CFE rats (n = 15/ group) were exposed
to 0, 0.25, 1.25 and 6.25 µg/L of air, for 23 hours daily. There was
no effect on the number of pregnancies or the number of live fetuses
in rats. Maternal toxicity was observed in rabbits exposed to high
doses (Thorpe et al., 1972). In another evaluation of reproductive
toxicity, Sherman rats (n = 6) were treated with 15 mg/kg dichlorvos
(i.p. on day 11 of gestation). While there was no treatment-related
effect on the number of pregnancies and live births, there was a
small, not significant increase in malformed fetuses (Kimbrough
and Gaines, 1968).
Studies conducted by Shell Chemical Co. found no adverse effect
on the reproductive performance of dichlorvos-treated pigs and
pregnant sows (Stanton et al., 1979; Young et al., 1979). In a two-
generation study in swine, 0, 200, 250, 288, 400 and 500 ppm
dichlorvos fed in diet over 37 months had no effect on the number,
viability, or reproductive performance of the offspring from the
exposed male and female pigs (Collins et al., 1971). Some of these
studies reported a small positive effect on litter weight of
dichlorvos-treated dams (Foster, 1968; Young et al., 1979). In one
study, crossbred sows were fed either basal diet, 500 ppm
dichlorvos, 250 ppm copper, or a combination of copper and
dichlorvos during gestation and lactation. There was a significant
reduction in pre-weaning mortality rate in the group fed dichlorvos
and copper (n = 41; p = 0.02) (Thacker, 1991). Two reasons are
possible for the increase in litter weight observed in some studies:
dichlorvos rids the dam of parasitic infestations, thus allowing for
better nourishment of the litter; or it affects the development of
the fetus directly. Authors of one study reported similar litter weight
gain for groups of dichlorvos-treated sows that were parasite-free
at the start of treatment, and groups that were parasite-infected,
indicating that dichlorvos was affecting litter weights in ways other
than just its anti-parasitic effect in the dam (Young et al., 1979).
In summary, evidence from available reproductive toxicology
studies indicates that exposure to dichlorvos does not adversely
affect the estrogen-dependent events such as implantation rates or
litter size in rabbits, mice, rats and pigs.
3. Tests of Mutagenicity:
a) Chromosome Aberrations in Occupationally Exposed
Humans:
Cytogenetic analysis of blood lymphocytes of male pesticide
applicators indicated significantly elevated sister chromatid
exchange (SCE) rates among sprayers (n = 29) who had applied
pesticides for more than a year without the use of protective
equipment (p < 0.05). However, dichlorvos was only one of many
pesticides used by these applicators (Crossen et al., 1978).
b) Mutagenicity Studies in Animals:
Many studies in bacteria, yeast, isolated cells and with isolated
DNA have reported a mutagenic potential of dichlorvos. However,
it has been argued that due to its short half-life, dichlorvos may
not have a major genotoxic effect in vivo in animals (Wright et al.,
1979). The genotoxic potential of dichlorvos has been studied in a
variety of ways to assay DNA damage in many different animal
systems: mice, rats, hamsters, and fish. Six of the 11 in vivo assays
discussed below have reported a genotoxic potential for dichlorvos.
Dominant lethal mutations were not observed to be increased in
the progeny of male mice treated with a single subtoxic dose of
dichlorvos, mated with untreated virgin females (Epstein et al.,
1972). A short term assay for unscheduled DNA synthesis (UDS)
in the forestomach of mice was initiated following the report by
Chan et al., (1991) of increased stomach cancers in dichlorvos-
treated mice (see IVB.1). Groups of B6C3F1 mice (five per sex)
were given 200 mg/kg of technical dichlorvos (99.8% pure) by
gavage, and sacrificed after 2, 4, 8, 10, 12 or 48 hours (Benford et
al., 1994). No induction of UDS was observed in response to
dichlorvos treatments. However, dichlorvos caused a significant
induction (p < 0.05) in the focal hyperplasia and replicative DNA
synthesis (RDS, an indicator of the number of cells entering S-
phase of the cell cycle) in the forestomach of male and female
mice. The authors of this study state that the absence of UDS argues
against a direct genotoxic potential of dichlorvos (Benford et al.,
1994). However, the induced hyperplasia, ignored by the authors,
may be indicating a tumor promoting potential of dichlorvos.
In another study, B6C3f1 mice injected intraperitoneally (i.p.) with
5, 15, 25, 35 mg/kg dichlorvos, had no significant induction of
SCE in the peripheral blood lymphocytes (Kligerman et al., 1985).
Male F344 rats fed 150 ppm and 300 ppm dichlorvos (> 96% pure)
for 14 days did not have any proliferative effects in the liver or
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kidneys (Cunningham et al., 1994). Cytogenetic analyses of bone
marrow and testis of Q strain mice treated to a single dose of 10
mg/kg dichlorvos did not indicate significant treatment-related
chromosome damage or clastogenic effects in either tissue
(Moutschen-Dahmen et al., 1981). There was no significant
increase in dominant lethal mutations which is consistent with the
cytogenetic observations.
In contrast, keratinocyte cells isolated from male HRA/Skh mice
after a single topical application of 0, 0.05, 0.1, 0.5 or 1.0%
dichlorvos had a significant, dose-related increase in incidence of
micronuclei (p < 0.001) (Tungul et al., 1991). A single topical
application of dichlorvos at a dose above 80 mM/kg was found to
significantly increase (p < 0.05) the percentage of nuclear
aberrations in the hair follicles of male CD1 mice (Schop et al.,
1990). Oral administration of 1/50, 1/75 and 1/100 of the lethal
dose required for 50% kill (LD
50
) of dichlorvos resulted in a
significant increase in the frequency of chromosome aberrations
in bone marrow cells of Wistar rats (Nehez et al., 1994). Injection
of 3, 6, 15 or 30 mg/kg dichlorvos i.p. to groups of female Syrian
hamsters (n = 6) was associated with a statistically significant
increase in chromosome aberrations at the two highest doses
(p < 0.05) (Dzwonkowska and Hubner, 1986). One study reported
genetic damage, assayed as sperm morphological abnormalities
in mice treated with i.p. injections of dichlorvos (Wyrobek and
Bruce, 1975). This  result was based on sperm morphology alone,
without any cytogenetic or genetic assay for chromosome damage.
One study has evaluated the genotoxic effects of 0 or 0.01 ppm
dichlorvos (100% pure, diluted to 50% in acetone emulsifier) in
fish kept in aquarium water. The rates of chromosomal aberrations
in fish exposed to the water for 24, 48, 72 and 96 hours were
significantly higher (p < 0.05). This study had limitations: the fish
used had been collected from many different areas and were not
isogeneic (genetically alike), or even farm raised, and may have
already been exposed to different chemicals. The analysis of only
one fish for each time point in this study prevented an analysis of
the background variability among control specimens (Rishi and
Grewal, 1995).
c) Mutagenicity Studies in Insects:
Dichlorvos was not found to induce sex-linked recessive lethal
mutations in Drosophila melanogaster (Sobels and Todd, 1979).
d) Mutagenicity Studies in Bacteria and Yeast:
The mutagenicity of dichlorvos has been extensively studied and
reviewed (IARC, 1991; Moutschen-Dahmen et al., 1984; Wild,
1975). In bacteria and yeast, dichlorvos was found to have a
mutagenic effect by many studies (Ashwood-Smith, 1972; Benigni
et al., 1980; Kada et al., 1980; Nagy et al., 1975; Shirasu et al.,
1976; Voogd et al., 1972). One recent study found no evidence for
mutagenicity of dichlorvos in bacteria (Hour et al., 1998).
The DNA-methylating ability of dichlorvos in bacteria and with
isolated DNA, has been implicated as the mechanism for its
mutagenicity by many authors (Braun et al., 1981; Segerback and
Ehrenberg, 1981; Wooder and Wright, 1981; Wright et al., 1979).
However, the DNA-alkylating ability of dichlorvos in vivo has
been found to be very weak (FAO/WHO, 1993; Segerback, 1981).
Dichlorvos has also been found to be more mutagenic in strains of
DNA polymerase-deficient bacteria, indicating that the DNA repair
machinery may play a role in preventing some of the dichlorvos
damage (Moutschen-Dahmen et al., 1984; Rosenkranz, 1973). In
contrast, another study found dichlorvos to be mutagenic in both
excision-repair competent, as well as excision-repair deficient
strains of Escherichia coli (Nagy et al., 1975).
Dichlorvos, at 0.1% volume per volume portion (v/v) in water
was observed to increase the mutation rates in four different
bacterial strains (Voogd et al., 1972). There was also a dose-
dependent effect in Salmonella typhimurium, the strain that was
tested with multiple doses in this study. In another study, dichlorvos,
dispersed in taurocholate micelles, was observed to be more
genotoxic in a modified SOS assay than when dissolved in 10%
dimethyl sulphonate (DMSO) (Venkat et al., 1995). Dichlorvos
was mixed with sodium taurocholate to form water-soluble
micelles, to better mimic its physiological state (taurocholate is
an end product of cholesterol metabolism found in bile salts). The
design of the colorimetric assay had the b-galactosidase gene under
the control of the SOS DNA repair gene, SulA, which allowed the
detection of any mutation that triggered the DNA repair system.
Dichlorvos, at concentrations close to 1 mM, induced prophage
excision in another assay of mutagenicity (Houk and DeMarini,
1987). Dichlorvos was found to be mutagenic in one of the two
strains of Salmonella that were tested in one study, providing
equivocal evidence on its mutagenic potential (Zeiger, 1987).
The mutagenicity of dichlorvos was recently compared by two
different assays: the Ames test, and a newly developed lactam test,
designed to detect revertant mutations in the b-lactamase gene
(Hour et al., 1998). Dichlorvos was not found to be mutagenic by
either of the two assays in this study.
e) Mutagenicity Studies in Isolated Animal Cells:
One study, presented as an abstract, has reported that dichlorvos
induced micronuclei in isolated human cells (lymphoblastoid)
(Doherty et al., 1996). Other studies in animal cells corroborate
this result. Chromosome aberrations and sister chromatid
exchanges (SCE) were significantly induced (p < 0.001) in a study
of isolated Chinese hamster ovary (CHO) cells that were cultured
in 1% dichlorvos (> 98% pure) (Tezuka et al., 1980). Dichlorvos
(98% pure) added to the culture medium, at 0.03 mM and 0.1 mM
concentration, caused a significant induction (p < 0.01) in SCE of
CHO cells (Nishio and Uyeki, 1981). Another study found
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dichlorvos at doses of 40, 200 and 1000 µg/ml to significantly
induce SCE (p < 0.005 for the trend) in CHO cells (Wang et al.,
1988). Dichlorvos was found to induce micronuclei and mutation
frequencies in a CHO / hypoxanthine-guanine phosphoribosyl
transferase assay (HGPRT assay) with or without S9 activation
(Oshiro et al., 1991).
Hepatocytes isolated from phenobarbitol-treated rats were
incubated with 500, 1000, 1500 or 2000 µM dichlorvos for 90
minutes (Yamano, 1996). Dichlorvos was found to significantly
increase cellular lipid peroxidation and single-strand DNA breaks
at doses 500 µM and above (p < 0.05). The DNA-damaging effects
caused by dichlorvos could not be completely blocked by
antioxidants, indicating a lipid peroxidation-independent effect.
Dichlorvos treatments of rat tracheal epithelial cells with doses 80
µg/ml or higher, caused a dose-dependent and significant induction
in SCE (p < 0.001), and a dose-dependent induction in
transformation rates (Lin et al., 1988).
4. Evidence of Tumor Promotion:
F344 rats that were fed 8 or 16 mg/kg/day dichlorvos, after
receiving a leukemia transplant, developed leukemia earlier than
rats that received the transplant alone (Dieter et al., 1990; Dieter
et al., 1989). These studies indicate that dichlorvos acts as a tumor
promoter for leukemia in rats.
A combination of 20 different pesticides, each at 100 times its
acceptable daily intake (ADI) level, was administered to F344 rats
that had been injected with a single dose of 200 mg/kg
diethylnitrosamine (DEN). Glutathione S-transferase P (GST-P)
foci were assayed as pre-neoplastic indicators of a carcinogenic
effect. The mixture of pesticides including dichlorvos was found
to significantly increase the incidence of GST-P positive foci in
the liver of DEN-treated rats (p < 0.05) (Ito et al., 1995). Since
dichlorvos was just one of the chemicals in the tumor promoting
mixture, its role as a tumor promoter cannot be determined from
this study.
5. Effects on Hepatic Enzymes:
One of the most potent effects of dichlorvos is the inhibition of
cholinesterase enzymes in the liver. It has been reported to be
neurotoxic as well. These toxic effects are not the kind that have
been linked to an increase in cancer risk and hence, have not been
included here.
6. Immunological Effects:
A chemical may indirectly affect the risk for cancer by suppressing
the ability of the bodyÕs defense system to fight cancer cells. There
is some evidence that suggests that exposure to dichlorvos may
compromise the immune response of exposed animals.
In one study, C57B1/6 mice were immunized with sheep
erythrocytes and treated with a single dose of 120 mg/kg dichlorvos
(96% pure) in corn oil (Casale et al., 1983). Two days after
treatment with dichlorvos, the treated-mice had a significantly
lower immunoglobulin M (IgM) response (p < 0.05) to the sheep
erythrocytes. The authors suggest that this immunotoxic effect may
be in part due to the known toxic effect of dichlorvos on serine
esterase enzymes. A later study found dichlorvos (98.5% pure) to
significantly suppress (p < 0.05) interleukin 2-driven proliferation
of mouse T cells (CTLL2) at concentrations ranging from 0.5 to
50 µM (Casale et al., 1993). While these results indicate that
dichlorvos has the potential to interfere with immune responses,
they do not help predict the effect of dichlorvos on the immune
response against cancer cells in these animals. Also, immune
response was evaluated to acute exposure only.
In a three-generation immunotoxicity assay, rats were treated with
0, 0.927, 1.27 or 1.85 mg/kg/day dichlorvos by gavage for five
days per week for 11 weeks and then allowed to mate. Treatment
of females was continued until weaning. Dichlorvos exposures
did not cause significant immunosuppression in the first generation.
However, in the second generation, rats that were treated with the
highest dose of dichlorvos had a significantly decreased plaque-
forming response (PFC) to immunization with sheep red blood
cells (p < 0.05) (Institoris et al., 1995). In the third generation, the
decrease in PFC response was not significant. The reason for the
different sensitivities of different generations to the immune toxic
effect of dichlorvos is not clear. It is difficult to determine if the
immunotoxic effect observed in this study could lead to a
teratogenic effect.
Male rabbits that were treated orally with technical grade
dichlorvos (93% pure) for six weeks had significantly suppressed
(p < 0.01) humoral-and cell-mediated immune responses at doses
higher than 1/20 of the LD
50
 for dichlorvos. The
immunosuppression was also significant at 1/40 of the LD
50
 for
dichlorvos (p < 0.05) (Desi et al., 1980).
Dichlorvos (98% pure) > 3 mg/L, had a significant
immunosuppressive effect (p < 0.05) on carp lymphocyte
proliferation and phagocytosis. It was found to completely suppress
any lymphocyte proliferation at concentrations of 24.5 mg/L or
higher (Dunier et al., 1991).
7. Summary of Other Relevant Data on Breast Cancer Risk:
Dichlorvos has been reported to have a mutagenic action in
bacteria, yeast and isolated cells. However, it has been argued that
due to its very short half-life, it may not cause irreparable DNA
damage in whole animals. Indeed, the evidence for the genotoxicity
of dichlorvos from in vivo studies is more equivocal; six studies
have observed a genotoxic effect of dichlorvos (Crossen et al.,
1978; Dzwonkowska and Hubner, 1986; Nehez et al., 1994; Rishi
and Grewal, 1995; Schop et al., 1990; Tungul et al., 1991) and
five studies have not (Benford et al., 1994; Cunningham et al.,
1994; Kligerman et al., 1985; Moutschen-Dahmen et al., 1981;
Sobels and Todd, 1979). Dichlorvos has been reported to cause
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immunosuppression (Casale et al., 1983; Casale et al., 1993; Desi
et al., 1980; Dunier et al., 1991; Institoris et al., 1995) and tumor
promotion in experimental animals (Benford et al., 1994; Dieter
et al., 1990; Dieter et al., 1989). Dichlorvos does not adversely
affect reproduction in mammals. It has not been tested adequately
for estrogenic effects.
VI.  Other Information:
A. Environmental Fate and Potential for Human Exposure:
Dichlorvos is rapidly absorbed and degraded in all mammalian
species (FAO/WHO, 1993). Dichlorvos metabolism after different
routes of administration in man, rat, mouse, swine and hamsters
has been reported to be rapid, with similar metabolites in all species
(Blair et al., 1975; Hutson et al., 1971a; Hutson and Hoadley,
1972a; 1972b; Hutson et al., 1971b; Page et al., 1971; Page et al.,
1972). Dichlorvos degradation follows two main pathways. It is
hydrolyzed to dimethylphosphate and dichloroacetaldehyde in the
plasma and liver. The vinyl-phosphate bond of dichlorvos is rapidly
cleaved as the first step in degradation. A smaller fraction of
dichlorvos can be converted to desmethyl-dichlorvos by the
glutathione-dependent enzymatic system, which breaks down to
methylphosphate and dichloroacetaldehyde. Intermediate
metabolites that have been  identified in tissues soon after exposure
are dimethyl phosphate, dichloroacetaldehyde, dichloroethanol,
dichloroacetic acid and desmethyl dichlorvos (Page et al., 1972).
There is no evidence of accumulation of dichlorvos or its
metabolites in the animal blood or tissues (WHO, 1989). Urine
and respired air are major routes for elimination in man and other
mammals (Hutson and Hoadley, 1972a).
With recent increased restrictions, the potential for dichlorvos
exposure for the general population is relatively low. Although
dichlorvos degrades rapidly, studies of populations that are
occupationally exposed in the past have reported detectable levels
of absorption of this insecticide. The potential for occupational
exposure to humans, although low, still exists.
1. Occupational Exposure:
An occupational exposure study of 22 pesticide applicators who
used three OPs including dichlorvos reported alkyl phosphate
metabolites in 96% of the urine samples collected within 24 hours
of a work shift (Hayes et al., 1980). A study of 13 human volunteers
who worked as pesticide applicators indicated dermal and
inhalation exposures, even among applicators who used protective
equipment (Das et al., 1983). At the end of a dayÕs work, average
dichlorvos residues were 75.85 µg/ft2 (0.1 ft2 = m2) on the back,
40.9 µg/ft2 on the chest, 7.02 µg/in2 (6.5 in2 = cm2) on the respirator
filter. Urine analysis indicated 0.32 µg to 1.39 µg dichlorvos
residues in the total urine sample collected on the day of application,
but levels approached zero by the next morning, indicating rapid
clearance (Das et al., 1983). These results were also observed in a
different study that analyzed OP metabolites in the urine samples
of six male pest control operators in Japan.  Workers exposed
primarily to dichlorvos had a sharp decline in urinary levels of
alkyl phosphates within a day of interruption of exposure,
indicating rapid clearance (Takamiya, 1994). In another study,
Mexican American grape harvesters (25 male and 11 female) were
monitored for exposure to OPs, including dichlorvos.
Cholinesterase inhibition was observed, especially in female
workers post-harvest. However, since there was no evidence of
dichlorvos residues on grape leaves, the authors suspect that this
group was exposed to OPs other than dichlorvos (Kraus et al.,
1981).
Air samples from commercial insecticide storage facilities and
vehicles used by applicators were analyzed for dichlorvos residues.
Storage facilities had much higher level of dichlorvos in air (0.53
ppb) compared to office rooms (0.04 ppb). Vehicles that were used
to store compressed air spraying equipment and the insecticide
had a mean air levels of 0.94 ppb dichlorvos (Wright and Leidy,
1980).
All these studies indicate that occupational exposure to dichlorvos
was frequent and detectable among pesticide applicators. As
mentioned earlier, dichlorvos ranked among the three most
frequently applied pesticides by pest control operators in 1974
(ATSDR, 1997). However, there are no epidemiological studies
available on the long-term health effects of dichlorvos among
pesticide applicators.
2. Potential of Exposure for the General Population:
a) Food and Water:
Dichlorvos residues on food are readily destroyed by washing and
cooking (IARC, 1991). Due to the short half-life of dichlorvos,
the potential for human exposure from food and water is relatively
low. No dichlorvos residues were found in Total-Diet Studies
carried out by the FDA during 1964 to 1979 (Johnson et al., 1981;
WHO, 1989). Total-Diet Studies done in the United Kingdom in
1966-67 did not report dichlorvos residues either (Abbott et al.,
1970). Analysis of food by the United States Department of
Agriculture (USDA) after dichlorvos vapor treatments of food
warehouse chambers indicated levels of dichlorvos less than or
equal to 0.1 ppm in flour and in packaged foods (Gillenwater et
al., 1971; Harein et al., 1971). In Canada, only one out of 262
bovine and porcine samples analyzed between 1973 and 1981 was
contaminated with dichlorvos residues (IARC, 1991). A study in
Japan on effects of food processing, reports that 40% to 80% of all
dichlorvos residues on soybeans can be removed with one or two
washes, respectively, and 95% of all dichlorvos is destroyed by
cooking for 2.5 minutes (Miyahara and Saito, 1994).
b) Air:
Air residues of dichlorvos have been reported as the major route
of exposure to humans in some studies. The Non-Occupational
Pesticide Exposure Study (NOPES) sponsored by the EPA was
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designed to monitor seasonal fluctuations and relative pesticide
exposure to populations in Jacksonville, Florida (high agricultural
pesticide use) and Springfield/Chicopee, Massachusetts (low, but
not negligible pesticide use). Air samples were collected in spring,
summer and winter, between 1986 to 1988. Levels in Jacksonville
were higher as expected, and those within the city were highest
during the summer. Dichlorvos was one of the top seven pesticides
found in high concentrations in indoor air in Jacksonville. It was
estimated that 33% of the studied population in Jacksonville had
detectable levels of dichlorvos in indoor air during summer,
compared to 2% of the population in Springfield/Chicopee. The
mean exposure to dichlorvos from air for residents of Jacksonville
was estimated at 1,248 ng/day, compared to 66 ng/day estimated
for residents of Springfield/Chicopee, Massachusetts (Whitmore
et al., 1994). There were no reports indicating dietary exposure to
dichlorvos, based on the data obtained from questionnaires on
dietary intakes, market basket surveys conducted by the USDA,
and the total diet studies conducted by the FDA between 1982 and
1987. The authors of this study concluded that air was the major
route of exposure to humans in both cities (Whitmore et al., 1994).
In another study, air samples from seven homes in New Jersey
were analyzed for dichlorvos. Six households did not have
detectable residues, but one household had a mean concentration
of 254.7 ng/m3 dichlorvos, with a peak level of 354.7 ng/m3
immediately after application. The residues reduced to non-
detectable levels eight weeks after treatment (Roinestad et al.,
1993).
A study of deposits on dichlorvos-treated domestic structures found
219 µg/ft2 dichlorvos deposited on the first day. There was some
persistence of the insecticide even after the fifth day with detectable
levels of 50.9 µg/ft2 (Das et al., 1983). Another study analyzed the
dissipation of dichlorvos after use of home foggers deployed in
accordance with the manufacturerÕs directions. Air levels of
dichlorvos fell to 1 mg/m3 within 60 minutes. The authors point
out that while this level may be acceptable for a TWA exposure of
eight hours at the workplace, it may not be the safe level for
prolonged non-occupational exposure for someone confined at
home. According to this study, safe re-entry levels of dichlorvos
for prolonged exposure (considered as 0.06 µg/cm2) are not reached
until 10 hours or more after application (Goh et al., 1987).
Perimeter outdoor applications of dichlorvos around domestic
dwellings were reported (presented only in an abstract) to cause
low residues of this insecticide in indoor air, but details of this
study were not available (Leidy and Stout, 1996). Shell
Development Company conducted a study of air and food residues
in 15 homes in Modesto, California, following the installation of
Vapona insecticide strips containing dichlorvos. This study
reported low residue averages of 0.06 µg/L in air after one day of
installation (Collins and DeVries, 1973). A total of 174 meals were
collected from these treated homes and analyzed for residues. Either
one or two strips were used in the kitchen or dining areas to treat
these homes. Twenty four of the meals were found to contain 0.02
ppm, seven had 0.03 ppm, and five had 0.04 ppm of Vapona
(dichlorvos) residues (Collins and DeVries, 1973). These results
indicate that low levels of food contamination can result from
dichlorvos residues in indoor air.
One study has estimated the Òworst case dose absorbedÓ from
dermal and oral exposure combined following indoor application
(presented only as an abstract). Exposure after 24 hours was
estimated to reach levels of dichlorvos that are known to produce
cholinesterase inhibition (Berteau and Mengle, 1986). Details of
the study design were not available.
c) Soil:
The half-life of dichlorvos has been estimated to be 16 days in
both sandy and silty clay soils (Sattar, 1990). A study that examined
the rates of dissipation of trichlorfon insecticide applied to turfgrass
reported rapid conversion of trichlorfon to dichlorvos, followed
by a decline in dislodgeable residues of dichlorvos to non-
detectable levels within five days (Murphy et al., 1996). Safe re-
entry time was estimated following lawn treatments with dichlorvos
in another study to range between 7 to 12 hours (Goh et al., 1986).
3. Storage and Excretion of Dichlorvos in Humans:
The clinical pharmacology of dichlorvos has been tested directly
in human volunteers in many studies (Blair et al., 1975; Hutson
and Hoadley, 1972a; Slomka and Hine, 1981). The effect of this
insecticide on blood enzymes was tested again in human volunteers
who were given small doses of dichlorvos recently, drawing
criticism from media and environmental groups (Cushman, 1998).
Dichlorvos is rapidly broken down in human blood, with a half-
life of 7 to 11 minutes (Blair et al., 1975).  A human male volunteer
was monitored after receiving an oral dose of [14C]-dichlorvos.
About 27% of the radioactivity was excreted within the first 8
hours in the CO
2
 exhaled from the lungs (Hutson and Hoadley,
1972a). Only 7.6% of the total dose was found to be excreted in
the urine in the 24 hours after ingestion. After 4 days, measurable
amounts of radioactivity could still be found in the urine, but by
the ninth day, the levels had dropped to 0.002% of the dosed
radioactivity.
A comparative analysis of excretion patterns in humans, hamsters,
rats and mice after oral ingestion suggests very similar metabolic
fate for dichlorvos in these species (Hutson and Hoadley, 1972a).
A recent study evaluated dichlorvos levels in blood of AlzheimerÕs
patients who were receiving metrifonate therapy for inhibition of
acetylcholinesterase. Metrifonate was non-enzymatically converted
to dichlorvos and rapidly degraded and cleared from the body of
these patients, with an estimated half-life of 1.90 to 3.12 hours
(Pettigrew et al., 1998).
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a) Lactation and Breast Milk:
Breast milk of women in a hospital maternity ward that used
Vapona strips did not inhibit cholinesterase enzymes in vitro. An
analysis of the enzymes in the blood of breast-fed infants of these
exposed mothers also indicated a lack of transfer of dichlorvos
through lactation (Cavagna et al., 1970). However, one dichlorvos
contaminated (0.1 ppm) breast milk sample was reported by a study
conducted in Taiwan [Yeh et al., as cited in (Sonawane, 1995)].
b) Adipose Tissues:
Studies of tissue distribution of dichlorvos in animals indicates
rapid clearance and no significant storage of this pesticide in body
tissues (Blair et al., 1975; Hutson et al., 1971a; 1971b; Hutson
and Hoadley, 1972a; 1972b). One study estimated the half-life of
dichlorvos in adipose tissue of animals to be 10.7 days (Garcia-
Repetto et al., 1995). An analysis of bovine carcasses sold in
Ontario, Canada (1969 to 1981) reported negligible amount
(usually 0.1 mg/kg) of dichlorvos in the fat tissue (Frank et al.,
1983).
c) Tissue Distribution:
An autopsy done one day after a fatal ingestion of dichlorvos in
xylene revealed congestion in lung and kidneys. Disregarding the
high levels in heart and spleen which could be due to diffusion
from the stomach, the insecticide was most concentrated in the
lung and kidneys, with relatively low concentrations in the blood,
liver and brain tissues (Shimuzu et al., 1996). Dichlorvos was found
mostly in the kidneys of male rats and mice after inhalation or
intravenous injection (Blair et al., 1975). Half-life times analyzed
in vitro ranged from 31 minutes in blood of male rats to 1.7 minutes
in rabbit blood (Blair et al., 1975). Studies on different mammalian
species have not revealed significant accumulation of dichlorvos
or its metabolites in animal tissues (Blair et al., 1975; Hutson et
al., 1971a; 1971b; Hutson and Hoadley, 1972a; Page et al., 1972).
Dichlorvos was not detected in the brain of rats treated by gavage.
Dichlorvos is not expected to cross the blood-brain barrier (Garcia-
Repetto et al., 1995).
VII. Summary and Recommendation for Breast
Cancer Risk Classification:
A. Breast Cancer Risk:
We propose that dichlorvos be classified in Group 3, not classifiable
as to its breast carcinogenicity in humans (please see Appendix B
for an explanation of the BCERF Breast Cancer Risk Classification
Scheme). While there is sufficient evidence for its overall
carcinogenicity, there is a lack of evidence of breast carcinogenicity
in humans, limited evidence of mammary carcinogenicity in
experimental animals and limited mechanistic evidence of its
potential to affect breast cancer risk. The evidence is summarized
below:
¥ Human studies: There were no studies available to evaluate the
breast carcinogenic effect of dichlorvos in humans.
¥ Animal studies: There is limited evidence on mammary gland
carcinogenicity of dichlorvos from studies in experimental animals.
Most studies done in experimental animals are invalid as cancer
bioassays by contemporary standards. One study that used
sufficient exposure time and large number of animals (Chan et al.,
1991), reported an increase in incidence of mammary gland
fibroadenomas/adenomas (benign) in one of the two groups of
female Fischer F344 rats that were fed dichlorvos. These results
need to be confirmed in a cancer bioassay in rats that uses at least
three treatment doses of dichlorvos and has better survival rates.
Such a study would allow an evaluation of whether dichlorvos
causes a dose-dependent increase in the incidence of benign
mammary tumors in rats, and if malignant tumors develop because
of higher survival rates of exposed animals.
¥ Related mechanisms: There is limited evidence for an effect of
dichlorvos on cancer risk through other related mechanisms.
Dichlorvos has been found by most investigators to be mutagenic
in single-cell organisms and in isolated cells (IARC, 1991).
Evidence for its genotoxic potential in vivo is equivocal, which
may be due to its very short half-life in animal blood (Blair et al.,
1975). There is limited evidence that dichlorvos may act as a tumor
promoter in rats, causing an increase in incidence of leukemia
(Dieter et al., 1990; Dieter et al., 1989), and in mice, by causing
increased hyperplasia in the stomach (Benford et al., 1994). There
is evidence that dichlorvos causes immunosuppression in mammals
(Casale et al., 1983; Casale et al., 1993; Desi et al., 1980; Dunier
et al., 1991; Institoris et al., 1995). It is not known however, if the
dichlorvos-caused immunosuppression in animals affects cancer
risk. While dichlorvos could be affecting risk for all cancer through
these mechanisms, these have not been tested directly for their
effect on breast cancer risk.
Dichlorvos use has now been restricted. It is rapidly degraded in
air, soil and water. It does not persist in the environment or in
body tissues, and is not found as a contaminant in drinking water
or food. Thus, the potential of the general population for exposure
to dichlorvos is low. However, there is still a risk for occupational
exposure to dichlorvos for those involved in the manufacture of
dichlorvos and other OPs; applicators that use foggers; and
veterinarians and people who work with livestock. Dichlorvos was
a very popular insecticide in the past and studies have shown that
pesticide applicators were at high risk for exposure to this
insecticide. As a non-specific carcinogen dichlorvos could also be
affecting breast cancer risk. However, currently there is no evidence
to support or refute this conclusion due to the lack of available
studies on cancer incidences among women pesticide applicators
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or those who had a high risk of exposure to dichlorvos. Hence, we
recommend further studies below on populations exposed to
dichlorvos through their work.
VIII. Identification of Research Gaps, and Other
Recommendations
There were no studies available to evaluate the incidence of breast
cancer among women who were exposed to this insecticide through
its manufacture or its application in agriculture and other industries.
Women pesticide applicators exposed to dichlorvos in the past need
to be followed for the incidence of breast cancer.
¥ The increase in benign tumors in the mammary gland of rats
treated with dichlorvos (Chan et al., 1991) needs verification.
Another cancer bioassay in rats, using at least three dose levels
and with high survival rates, is needed to confirm if dichlorvos
causes mammary gland neoplasms. These dichlorvos-treated
rats should also be evaluated for incidence of leukemia,
pancreatic tumors and tumors of the forestomach.
¥ Small case-control studies have indicated a higher risk for
leukemia among farmers who used dichlorvos most frequently.
Larger case-control studies are needed for incidence of leukemia
among men and women who used this insecticide for dairy,
poultry or other livestock.
¥ One small case-control study has observed an increased
incidence of childhood brain cancers in association with
dichlorvos exposure. However, the very small numbers and lack
of details on exposure in this study do not permit a meaningful
conclusion regarding the carcinogenicity of dichlorvos. Larger
case-controls studies of populations exposed to dichlorvos as
children are needed to evaluate the risk of childhood brain
cancer in association with home use of dichlorvos.
¥ There is some evidence that dichlorvos may promote the
incidence of leukemia in rats treated with leukemic spleen cell
transplants. Similar studies should be conducted with
transplanted mammary tumor cells to determine if dichlorvos
can promote the incidence of mammary tumors.
¥ Studies in experimental animals indicate that dichlorvos causes
immune suppression. Experimental animals should be tested
with mammary tumor cells to determine if more tumors are
established in dichlorvos-treated animals as a result of their
immune suppression.
¥ The estrogenicity of dichlorvos needs to be studied in in vitro
assays.
IX. Summary of New Human Studies Currently
Being Conducted
Studies of Occupational CancerÑPesticides:
(Alavanja, M., Blair, A., Zahm, S., extracted from the
CancerNet at NCI and Personal Communication)
The ÒAgricultural Health StudyÓ proposes to look at the
relationship between exposures to agricultural chemicals, including
pesticides, and cancer risk. Enrollment in this study includes 90,000
men and women farmers, pesticide applicators and farmerÕs wives
from Iowa and North Carolina. Besides conducting interviews to
determine pesticide use, it will also seek information on lifestyle
factors, medical and family history of disease and diet.
Study of Agricultural Exposures and Cancer Risk
(Ward, M., Heineman, E., Zahm, S. and Blair, A., Personal
Communication)
Also ongoing at the NCI, are case-control studies of brain and
stomach cancer in Nebraska, designed to evaluate the risk of cancer
from agricultural exposures, including pesticides.
Organophosphate Immunoactivity
(Albrecht, R.M., University of Wisconsin, Madison extracted
from the CRISP Database).
An ongoing study seeks to identify alterations in immune cells
that are caused by organophosphate chemicals. Immune responses,
gene expression and cell differentiation of monocyte/macrophage
precursor cells will be followed in the presence and absence of
triphenyl phosphate. Murine and human primary cell cultures and
cell lines will be tested.
Occupational Injury in Hispanic Farmworker Families
(Principal Investigator: McCurdy, S.A., University of
California, Davis, extracted from the CRISP Database).
Migrant and seasonal workers in California will be evaluated for
occupational injury in association with organophosphate exposure,
piece-work versus hourly pay, language appropriate safety training,
and the role of multiple employment. The cohort is expected to
consist of 500 farmworker families who live in six Migrant Housing
Centers close to Davis, California.
Role of Dichlorvos in Gulf War Illnesses
(A Presidential Committee on Gulf War VeteranÕs Illnesses,
extracted from http://www.gwvi.gov/ch4.html)
Dichlorvos is one of the OP documented as being shipped for use
during the Gulf War. A Presidential Committee on Gulf War
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VeteranÕs Illnesses has reported on several risk factors in veterans
of this war, including exposure to OPs including dichlorvos. This
committee was terminated in November, 1997. However, the
Center for Disease Control and Prevention (CDC), the National
Institutes of Health (NIH) and the Agency for Toxic Substances
and Disease Registry (ATSDR) have co-sponsored a conference
with the aim of developing a research plan to investigate any
relationship between chemical exposures and illnesses among Gulf
war veterans (Dr. T.D. Spittler, Personal Communication).
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XI.  Appendix A.  Common Abbreviations, Acronyms and Symbols
ADI acceptable daily intake
AFB
1
aflatoxin B
1
BCERF Program on Breast Cancer and Environmental
Risk Factors in New York State, based the
CornellÕs Center for the Environment, Institute
of Comparative and Environmental Toxicology
CAS Chemical Abstract Service
CFE rats Carworth Farm E strain rats
CfE Cornell UniversityÕs Center for the Environment
CHO Chinese hamster ovary
CI Confidence Interval
Cl chlorine
CRISP Computer Retrieval of Information on Scientific
Projects; database of scientific intra and extra
mural projects supported by the Dept. of Health
and Human Services (i.e., NIH, EPA, USDA)
DDVP dichlorovinyl dimethylphosphate
DEN diethylnitrosamine
DMSO dimethyl sulphonate
DNA deoxyribonucleic acid
EPA Environmental Protection Agency
ER estrogen receptor
E-SCREEN screening assay for estrogenicity that measures
proliferative response in estrogen-dependent
breast tumor cells
FDA Food and Drug Administration
FFDCA Federal Food, Drug and Cosmetic Act
ft foot
GST-P glutathione-S-transferase positive
h hour
HA The health advisories are non-enforceable limits
of the concentration of the chemical in the
drinking water that is not expected to cause any
adverse noncarcinogenic health effects when
consumed for no more than the time period
specified, with a margin of safety
HGPRT hypoxanthine-guanine phosphoribosyl 
transferase assay
IARC International Agency for Research on Cancer,
headquartered in Lyon, France
ICET Institute for Comparative and Environmental
Toxicology
IgM immunoglobulin M
in inch
i.p. interperitoneal
IRIS Integrated Risk Information System; Database
maintained by EPA available through the 
National Library of Medicine MEDLARS 
system.
kg kilogram
L liter
lb pound
LD
50
lethal dose for 50% kill
m meter
µg microgram
mg milligram
MCF-7 Michigan Cancer Foundation; cells derived from
human breast tumor
MCL Maximum Contaminant Level; enforceable limit
set by EPA which sets the maximum level of a
contaminate in a public drinking water supply
MTD maximum tolerated dose
n number of subjects/animals in the group
NCI National Cancer Institute
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ng nanogram
NHL non-HodgkinÕs lymphoma
NIOSH National Institute of Occupational Safety and
Health
NIEHS National Institute of Environmental Health and
Safety
NIH National Institutes of Health
NTIS National Technical Information Service; 
repository for federal agency technical reports
NTP National Toxicology Program
NY New York
NYS New York State
OP organophosphate pesticide
OR Odds Ratio
OSHA Occupational Safety and Health Administration
PFC plaque forming cells
ppb parts per billion
ppm parts per million
RDS replicative DNA synthesis
RR Relative Risk
SCE sister chromatid exchange
SMR standardized mortality ratio, the ratio of deaths
among a cohort, to the expected number of
deaths, multiplied by 100
SSB single stranded breaks
TWA Time-weighted average
UDS unscheduled DNA synthesis
U.S. United States
USDA United States Department of Agriculture
USEPA United States Environmental Protection Agency
WHO World Health Organization
Symbols:
α alpha
β beta
γ gamma
µg microgram
µM micromolar
< less than
> greater than
% percent
p p value
+ plus or minus
= equal to
¤ registered trademark
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XII Appendix B. Critical Evaluations of Breast Cancer Risk
This includes an overview of the Critical Evaluations and explanation of the BCERF Breast Cancer Risk Classification Scheme
The Process
Starting Point - Existing Critical Evaluations on Evidence of Carcinogenicity
IARC Monographs (International Agency for Research on Cancer)
NTP ARC (National Toxicology Program, Annual Report on Carcinogens)
ATSDR (Agency for Toxic Substances and Disease Registry)
Conduct Literature Searches using databases to obtain historical and the most recent information; i.e. Toxline, Medline, Biosis, Cancerlit
Peer-reviewed scientific literature-available through Cornell libraries and interlibrary loans.
Technical Reports-NTIS-National Technical Information Service
TOXNET databasesÑEPAÕs IRIS database source of oncogenicity and regulatory status information
Grey literatureÑStudies submitted to EPA that are not published:
-Industry generated oncogenicity studies
-Some abstracts (short summaries) are on line (IRIS database)
-Request reports from industry
-Request reports from EPA through Freedom of Information Act
The critical evaluation will include some general background information, including chemical name, CAS#, trade name, history of use,
and current regulatory status.
Evidence of cancer in other (non-breast) organ systems will be provided in synopsis form with some critical commentary, along with the
current overall carcinogenicity classification by international (IARC) and U.S. Federal Agencies (NTP, EPA).
Human epidemiological studies, animal studies, and other relevant studies on possible mechanisms of carcinogenesis are critically
evaluated for evidence of exposure to agent and breast cancer risk based on Òstrength of evidenceÓ approach, according to a modification
of IARC criteria as listed in the IARC Preamble.  (See below for a more detailed explanation of the BCERF Breast Cancer Risk Classification
scheme)
The emphasis of the document is the critical evaluation of the evidence for breast cancer carcinogenicity, classification of the agentÕs
breast cancer risk, identification of research gaps, and recommendations for future studies.  A section will also be devoted to brief
summaries of new research studies that are in progress.  A bibliography with all cited literature is included in each critical evaluation.
Major international, federal and state agencies will be provided with copies of our report.
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General Outline of BCERF Critical Evaluations
I. Chemical Information
A. Common Name
B. Chemical Name(s)
C. Chemical Formula(s)
D. Trade Name(s)
E. CAS # (Chemical Abstract Subject Number)
F. Chemical Structure
II. History of Use
1. Date of first registration
2. Uses
3. Past Usage/If available, current usage levels in US and NYS
III. Current Regulatory Status
A. Current Regulatory Status, EPA
B. Other sections as applicable
IV. Summary on Evidence of Overall Carcinogenicity (Non-Breast Sites)
A. Human Studies
B. Animal Studies
C. Current Classification of Carcinogenicity by other Agencies
1. IARC (International Agency for Research on Cancer)
2. NTP (National Toxicology Program)
3. EPA (Environmental Protection Agency)
V. Critical Evaluation of the Scientific Evidence for Breast Carcinogenicity
A. Humans Studies will include:
1. Case-Studies
2. Human Epidemiological Cohort Studies
3. Human Epidemiological Case-Control Studies
B. Experimental Animal Studies
C. Other Relevant Information, including mechanisms by which exposure may affect breast cancer risk (examples: co-
carcino genicity, estrogenicity, endocrine disruptor, mutagenicity, tumor promotion, cell proliferation, oncogene/tumor 
suppressor gene expression, immune function, etc.)
VI. Other Relevant Information
A. Specific for the pesticide; (i.e. may include information on environmental fate)
B. When available will summarize information on detection /accumulation in human tissues/and validation of biomarkers
VII. Summary, Conclusions, Recommendation for Classification
VIII.  Identification of Research Gaps, and Other Recommendations
IX. Brief Summaries of New Human Studies Currently Being Conducted
X. Bibliography
XI. Appendix A. Common Abbreviations, Acronyms and Symbols
XII. Appendix B. Critical Evaluations of Breast Cancer Risk
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BCERF Breast Cancer Risk Classification Scheme & Brief Definitions of Sufficient, Limited and Inadequate Evidence:
(adapted for breast carcinogenicity from the IARC Preamble by S.M. Snedeker)
Group 1:  Human breast carcinogen; sufficient evidence of
carcinogenicity to humans is necessary.  Sufficient evidence is
considered to be evidence that a causal relationship has been
established between exposure to the agent and human breast cancer.
Group 2A:  Probable breast carcinogen; this category generally
includes agents for which there is 1) limited evidence  of breast
carcinogenicity in humans and sufficient evidence  of mammary
carcinogenicity in experimental animals.  The classification may
also be used when there is 2) limited evidence  of breast
carcinogenicity in humans and strong supporting evidence from
other relevant data, or when there is 3) sufficient evidence  of
mammary carcinogenicity in experimental animals and strong
supporting evidence from other relevant data.
Group 2B:  Possible breast carcinogen; this category generally
includes agents for which there is 1) limited evidence  in humans
in the absence of sufficient evidence  in experimental animals; 2)
inadequate evidence  of carcinogenicity in humans or when human
data is nonexistent but there is sufficient evidence  of
carcinogenicity in experimental animals, 3) inadequate evidence
or no data in humans but with limited evidence  of carcinogenicity
in experimental animals together with supporting evidence from
other relevant data.
Group 2C:  Potential to affect breast cancer risk; this category
includes agents for which there is inadequate or nonexistent
human and animal data, but there is supporting evidence from
other relevant data that identifies a mechanism by which the agent
may affect breast cancer risk.  Examples are, but are not limited
to: evidence of agentÕs estrogenicity, disruption of estrogen
metabolism resulting in potential to affect exposure to estrogen;
evidence of breast tumor promotion, progression or co-
carcinogenicity; increased expression of proto-oncogenes or
oncogenes; evidence of inactivation of tumor suppressor gene
associated with breast cancer; evidence of adverse effect on
immune function; or evidence of a structural similarity to a known
breast carcinogen (structure-activity relationship).
Group 3: Not classifiable as to its breast carcinogenicity to humans.
Agents are placed in this category when they do not fall into any
other group.
Group 4: Probably not a breast carcinogen in humans: This
category is used for agents for which there is evidence suggesting
a lack of breast carcinogenicity in human studies and in animal
studies, together with a lack of related evidence which may predict
breast cancer risk. The absence of studies does not constitute
evidence for a lack of breast carcinogenicity.
Human Studies
Sufficient evidence of carcinogenicity in humans:  Must have
established evidence between exposure to the agent and human
breast cancer.  Case-reports are given the least weight in considering
carcinogenicity data in humansÑthey are suggestive of a
relationship, but by themselves cannot demonstrate causality.
Consistent, case-control studies which have controlled for
confounding factors and have found high relative risks of
developing breast cancer in relation to an identified exposure are
given the most weight in determining a causal relationship.
Limited evidence of breast carcinogenicity in humans: A
positive association has been observed between exposure to the
agent and breast cancer, but chance, bias or confounding factors
could not be ruled out.
Inadequate evidence of breast carcinogenicity in humans: The
available studies are of insufficient quality, consistency or statistical
power to permit a conclusion regarding the presence or absence of
a causal association.
Experimental Animal Studies
Sufficient evidence of breast carcinogenicity in animals:
Evidence of malignant tumors or combination of benign and
malignant tumors in (a) two or more species of animals, (b) or two
or more independent studies in one species carried out at different
times or in different laboratories or under different protocols.
Limited evidence of breast carcinogenicity in animals: The
studies suggest a carcinogenic effect, but are limited for making a
definitive evaluation because: (a) the evidence of carcinogenicity
is restricted to a single experiment; (b) there are unresolved
questions regarding the adequacy of the design, conduct or
interpretation of the study; or (c) the agent increases the incidence
of only benign neoplasms of lesions of uncertain neoplastic
potential, or of certain neoplasms which may occur spontaneously
in high incidences in certain strains of animals.
Inadequate evidence of breast carcinogenicity in animals: The
studies cannot be interpreted as showing either the presence or
absence of a carcinogenic effect because of major qualitative or
quantitative limitations.
